InvestorsHub Logo
Followers 31
Posts 2056
Boards Moderated 0
Alias Born 01/02/2019

Re: None

Tuesday, 02/08/2022 11:36:29 AM

Tuesday, February 08, 2022 11:36:29 AM

Post# of 730552
Yet the stock is red on the day even after the pump piece. hmmmmmmmmmmm. Can't produce what isn't approved. Just shows what the market thinks of the pump piece and its contents.

8 February, 2022 - 11:15 By Tony Quested
Sawston cell and gene therapy hothouse on exponential growth curve.

One of the world’s most capable facilities to advance cell and gene therapy innovation and manufacture personalised cancer cures is gathering momentum at the heart of the Cambridge BioMedTech cluster.
Chief Operating Officer Dr Mike Scott, who previously enjoyed 28 years with Cambridge University Hospitals, says the Sawston hothouse – run by Advent BioServices under a service contract for US-based Northwest Biotherapeutics which owns the long-term facility lease – is “on an exponential growth curve” less than a year after opening its doors.
Its various laboratories, GMP clean rooms, cold room storage – to cryostorage temperatures – and biobank are already being used to good effect by Advent on behalf of NW Bio and various external clients – and the partners haven’t even started any external marketing as yet.
Furthermore, Advent is only utilising a relatively modest percentage of the capacity that will eventually be developed to expand production and capability in a number of HealthTec specialisms from tailored cancer vaccines to a raft of personalised cancer treatments.
Advent and NW Bio, who are developing the facility were buoyed and are already exploiting the recent award of specialist manufacturing and tissue handling approvals that should boost demand and productivity. Approval was recently received from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) of a licence for manufacture of GMP (clinical grade) cell therapy products at the facility.
The MHRA licence enables the manufacture of DCVax-L products to get underway at Sawston in addition to continuing at a smaller GMP (good manufacturing productivity) facility in London.


Pumpernickel YuYUUUUUUUUUUUU....LALAAAAAAAAAAAAA...YuLAYuLAYuuuuuuuuuuuuuuuuuuuu..............AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAWHOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOoooooooooooooooooooooooooooooooeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News